Pressure BioSciences (OTCQB: PBIO) today announced the
featuring of its HUB platform of unique, ultra-high pressure instruments in
three presentations at the world’s largest annual food science conference, the
Institute of Food Technologists (“IFT”), held in New Orleans, Louisiana,
earlier this month. According to the update, the presentations reported the use
of PBIO’s HUB440 and HUB880 Explorer systems to advance understanding of the
effects of high pressure processing (“HPP”) on serious food-borne pathogens in
liquid food products and ground meat, as well as the decontamination of such
pathogens. “The need for safer food is a world-wide concern. In
recognition, the United Nations proclaimed June 7, 2019 as the first World Food
Safety Day,” PBIO President and CEO Richard T. Schumacher said in the news release.
“HPP currently plays an important role in food safety: although this unique
process is barely 20 years old, it has nonetheless already grown into an
estimated $20 billion market. By 2026, the projected market size of the
high pressure processing food market could reach approximately $42 billion
(Visiongain, 2016). We believe that presentations such as Dr.
Fouladkhah’s at this year’s IFT Conference will help generate awareness of our
new, powerful yet affordable bench-top HUB family of products in the food
industry, government, military, and academic laboratory environment, and that
this added exposure will result in an increased demand for our HUB equipment in
this large and growing market.”
To view the full press release, visit http://ibn.fm/QCYYF
About Pressure BioSciences Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the
development and sale of innovative, broadly enabling, pressure-based solutions
for the worldwide life sciences industry. The company’s products are based on
the unique properties of both constant (i.e., static) and alternating (i.e.,
pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented
enabling technology platform that uses alternating cycles of hydrostatic
pressure between ambient and ultra-high levels to safely and reproducibly
control bio-molecular interactions (e.g., cell lysis, biomolecule extraction).
PBIO’s primary focus is in the development of PCT-based products for biomarker
and target discovery, drug design and development, biotherapeutics
characterization and quality control, soil & plant biology, forensics, and
counter-bioterror applications. Additionally, major new market opportunities
have emerged in the use of its pressure-based technologies in the following
areas: (1) the use of its recently acquired PreEMT technology from BaroFold,
Inc. to allow entry into the biologics contract research services sector, and
(2) the use of its recently-patented, scalable, high-efficiency, pressure-based
Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of
otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher
quality, homogenized, extended shelf-life or room temperature stable low-acid
liquid foods that cannot be effectively preserved using existing non-thermal
technologies. For more information, visit the company’s website at www.PressureBiosciences.com.
NOTE TO INVESTORS: The latest news and updates
relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise necessary
to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
